105 filings
Page 4 of 6
8-K
5bfpnrjdste4
10 Nov 22
Talaris Therapeutics Announces Third Quarter Financial Results and Corporate Update
7:12am
8-K
p7e5tblksuntli 3r
20 Oct 22
Talaris Therapeutics Provides Update on FREEDOM-1 Phase 3 Clinical Trial
7:12am
EFFECT
nb2mz1myfqjkz mhcaiw
26 Aug 22
Notice of effectiveness
12:15am
CORRESP
iipd 1e1y7x8pq
23 Aug 22
Correspondence with SEC
12:00am
UPLOAD
i15gjrzs6fqzaodcj
22 Aug 22
Letter from SEC
12:00am
S-3
yt2o4zl6y4
15 Aug 22
Shelf registration
5:06pm
8-K
ev8m4c6td793
15 Aug 22
Talaris Therapeutics Announces Second Quarter Financial Results and Corporate Update
7:13am
8-K
gw3oykn
30 Jun 22
Other Events
4:54pm
8-K
ewgf54b1 fnt4z5zkgoi
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:09pm
8-K
lz4 e3nj674wzrl8
17 May 22
Talaris Therapeutics Announces Changes to Board of Directors
8:29am
8-K
vapr jajddeiqo
12 May 22
Talaris Therapeutics Announces First Quarter Financial Results and Corporate Update
4:07pm
DEFA14A
cir9hbk2ivfo
29 Apr 22
Additional proxy soliciting materials
4:27pm
DEF 14A
kcj8w0jlo4ij8vera9
29 Apr 22
Definitive proxy
4:24pm
S-8
266 qq928m31n0
17 Mar 22
Registration of securities for employees
4:41pm
10-K
par 40ari1sk2icm7vz
17 Mar 22
Annual report
4:31pm
8-K
ihwjgv 4plgcpu
17 Mar 22
Talaris Therapeutics Announces Fourth Quarter and Year-End Financial Results and Provides Business Update
4:13pm
8-K
e5pa 31rfr6jhfih
12 Nov 21
Talaris Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
7:00am